These results empirically confirm that Cmpk2 deficiency is a causative factor for the formation of calcified deposits in the mouse brain, and further support that the CMPK2 mutation can explain brain calcification phenotype in our FBC patients. This evidence concerns the gene CMPK2 and complete blood cell count.